OCUL ▲ +0.4% - Ocular Therapeutix, Inc. $OCUL - Ocular Therapeutix™ Announces Positive Pre-NDA Meeting with U.S. FDA for AXPAXLI™ in Wet AMD Ocular Therapeutix rose 0.4% following the company's announcement of a positive pre-NDA meeting with the FDA regarding AXPAXLI for wet age-related macular degeneration, a key milestone that clears the path toward formal submission of a new drug application. 15-SEP-2026 07:00 AM ET